![]() |
市场调查报告书
商品编码
1959303
2026 年至 2035 年机能性食品市场中后生元成分的成长要素、产业趋势和预测。Postbiotic Ingredients in Functional Foods Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
2025 年,全球机能性食品用后生元成分市场价值为 5.974 亿美元,预计到 2035 年将以 11.3% 的复合年增长率增长至 17.4 亿美元。

这一增长主要得益于消费者对肠道健康和微生物组科学的日益关注,以及对稳定性高、易于配製的功能性成分需求的不断增长。后生元成分使食品生产商能够在不製作流程和储存过程中维持活性菌群所带来的配方难题的情况下,提供与微生物组相关的益处。因此,越来越多的品牌开始采用后生元作为益生菌的低风险替代品,同时保持其在消化健康和免疫支持方面的强大市场地位。关键地区的监管政策细化以及以营养价值和便利性为优先考虑的食品形式的融合,正在加速产品创新。消费者对发酵食品和有益肠道产品的广泛兴趣进一步增强了市场需求,生产商正在开发涵盖多个品类的微生物组支持配方。耐热后生元成分的应用正在不断增加,尤其是在传统活性菌丛稳定性难以保证的应用中。消费者对消化健康的日益增长且可量化的兴趣将继续支撑市场的长期扩张。
| 市场范围 | |
|---|---|
| 开始年份 | 2025 |
| 预测年份 | 2026-2035 |
| 起始值 | 5.974亿美元 |
| 预测金额 | 17.4亿美元 |
| 复合年增长率 | 11.3% |
预计到2025年,胜肽和蛋白质细分市场将占据22%的市场份额,并在2035年之前以12.2%的复合年增长率成长。原料供应商正从提供单一成分转向提供多功能混合物,这些混合物结合了胜肽、酵素、细胞组分、维生素和其他生物活性化合物。这些解决方案以标准化标籤为目标,定位为配料,旨在提供稳定的效力、更佳的风味和更高的生产效率。在商业策略中,跨品类相容性日益重要,这使得这些产品能够应用于乳製品、饮料和零食配方,同时支持差异化的功能性宣称,并辅以稳定性检验和文件记录。
预计到2025年,乳製品和发酵乳製品市场份额将达到38%,到2035年将以10.9%的复合年增长率成长。该细分市场之所以维持核心地位,是因为其发酵带来的健康益处以及与消费者既有消费习惯的天然亲和性。製造商正在将后生元成分添加到各种乳製品中,以提高配方稳定性,确保产品功能始终如一,同时又不影响消费者的感官体验。在维持传统口味的同时,增强消化健康讯息,此优势持续推动着此品类的市场成长。
预计到2025年,北美机能性食品用后生元成分市场规模将达到1.569亿美元,到2035年将达到4.604亿美元,主要得益于主流肠道健康机能性食品的强劲创新。美国凭藉其成熟的机能性食品品牌和原料供应商生态系统,正引领区域成长。市场扩张的驱动因素包括:膳食补充剂概念在食品饮料行业的跨界应用、消化健康产品零售分销网络的拓展,以及消费者对便捷携带式产品形式的高度认可。
(註:贸易统计数据仅涵盖主要国家。)
The Global Postbiotic Ingredients in Functional Foods Market was valued at USD 597.4 million in 2025 and is estimated to grow at a CAGR of 11.3% to reach USD 1.74 billion by 2035.

Growth is driven by rising consumer awareness of gut health and microbiome science, alongside increasing demand for stable and easy-to-formulate functional ingredients. Postbiotic ingredients offer food manufacturers the ability to deliver microbiome-related benefits without the formulation challenges linked to maintaining live cultures during processing and shelf life. As a result, brands are increasingly turning to postbiotics as a lower-risk alternative to probiotics while maintaining strong positioning around digestive health and immune support. Regulatory clarity in key regions, combined with the convergence of nutrition and convenience-driven food formats, is accelerating product innovation. Broader interest in fermented and gut-friendly products has further strengthened demand, with manufacturers developing microbiome-supportive formulations across multiple categories. Heat-stable postbiotic ingredients are gaining traction, particularly in applications where traditional live cultures face stability limitations. Quantifiable consumer interest in digestive wellness continues to support long-term market expansion.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $597.4 Million |
| Forecast Value | $1.74 Billion |
| CAGR | 11.3% |
The peptides and proteins segment accounted for 22% share in 2025 and is expected to grow at a CAGR of 12.2% through 2035. Ingredient suppliers are moving beyond single-component offerings toward multifunctional blends that combine peptides, enzymes, cell fractions, vitamins, and additional bioactive compounds. These solutions are positioned as standardized, label-friendly ingredients that deliver consistent potency, improved flavor profiles, and greater manufacturing efficiency. Commercial strategies increasingly emphasize cross-category compatibility, enabling use across dairy, beverage, and snack formulations while supporting differentiated functional claims backed by stability validation and documentation.
The dairy and fermented dairy applications segment held 38% share in 2025 and is forecast to grow at a CAGR of 10.9% by 2035. This segment remains central due to its natural alignment with fermentation-based health narratives and established consumption habits. Manufacturers are incorporating postbiotic ingredients into a wide range of dairy-based products to enhance formulation stability and ensure consistent functional positioning without compromising sensory expectations. The ability to reinforce digestive health messaging while maintaining traditional taste profiles continues to strengthen adoption within this category.
North America Postbiotic Ingredients in Functional Foods Market accounted for USD 156.9 million in 2025 and is projected to reach USD 460.4 million by 2035, supported by strong innovation in mainstream gut-health functional foods. The United States leads regional growth through a well-developed ecosystem of functional food brands and ingredient suppliers. Market expansion benefits from the crossover of dietary supplement concepts into food and beverage applications, widespread retail availability of digestive wellness products, and high consumer acceptance of convenient, on-the-go functional formats.
Key companies operating in the Global Postbiotic Ingredients in Functional Foods Market include DSM-Firmenich, IFF (International Flavors & Fragrances), ADM, Kerry Group, BASF, Novonesis, Cargill, Givaudan, Evonik, and DuPont (IFF legacy Danisco). Companies in the Postbiotic Ingredients in Functional Foods Market are strengthening their competitive position through targeted research and development, strategic partnerships with food manufacturers, and portfolio diversification. Many players are investing in clinically supported formulations to substantiate claims related to digestive and immune health. Expanding multifunctional ingredient blends enhances cross-category application flexibility and improves formulation efficiency for brand owners. Firms are also prioritizing regulatory alignment and clean-label positioning to meet evolving consumer expectations. Strategic acquisitions and collaborations are enabling companies to broaden their geographic reach and accelerate innovation pipelines.
( Note: the trade statistics will be provided for key countries only)